This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Fred L. Cohen, MD
Self-Care III (In WCA Hospital) 207 Foote Ave Jamestown, NY 14701

Arch Neurol. 1979;36(10):662.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Dr Nelson raises several points in his thoughtful letter. The first has to do with complications of administration of methylprednisolone acetate. Morbidity in any procedure is the ratio of complications to the number of procedures performed. Dr Nelson and his colleagues¹ reported three complications in 23 patients (13%). Goldstein et al² reported two complications in 31 patients (5.3%). Although there are no statistics available on the number of intrathecal methylprednisolone acetate injections performed throughout the world since 1960, the number must be impressive given the ease of administration and lack of better treatment modalities in the disease processes for which it has been used. Sehgal and Gardner³ reported over 1,000 injections with no complications, and six subjects in this series had autopsies that showed normal arachnoid and spinal cord.

The second point bears on the production of arachnoiditis. Most references agree that the major concentration of intrathecally administered . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?